NCT06894823Recruiting
Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT)
Source: ClinicalTrials.gov · Last updated 25 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
COESIT aims to establish a network of reference laboratories in the central-southern regions of Italy for the genetic and molecular characterization of tumors, with the goal of implementing precision and personalized oncology in clinical practice.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 16000 (estimated)
- First submitted
- 13 Mar 2025
- Start date
- 10 Dec 2024
- Primary completion date
- Dec 2028
- Lead sponsor
- National Cancer Institute, Naples
- Diseases
- Childhood cancers
- NCT number
- NCT06894823
What you commit to
- Study type: Observational
- Planned participants: 16000
- From 10 Dec 2024 to the primary completion date, Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Cancer patients
- Patients from the central-southern regions
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale Coordinator of this site? Confirm its status | Naples | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.